St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Mary Powers
Mary Powers is a former member of the Strategic Communications, Education and Outreach Department at St. Jude Children’s Research Hospital.
Stories by Mary Powers
Childhood Solid Tumor Network moves to the cloud with additional data and analytic tools
Scientists interested in studying pediatric solid tumors now have this comprehensive, interactive online shop for patient-derived tumor information.
Interested in childhood cancer survivorship research? Apply now for support to get started.
Get your survivorship study funded by applying for this career development award.
Searching for the next pandemic flu virus? There’s another factor to keep in mind.
Researchers find the stability of this protein is key to the pandemic potential of swine flu.
A vaccine to prevent ear infections? Here’s the latest.
Almost everyone gets ear infections. This vaccine may change that.
Legendary flu hunter offers tips to stay healthy during a pandemic
This researcher's recommendations on coronavirus are based on 65 years of infectious diseases and viral research.
A neuroscientist finds a niche at St. Jude
A neuroscientist studying the brain’s fight-or-flight response is learning more about developing brains and this about pediatric brain tumors.
Pushing the limits to find relationship between proteomics and Alzheimer’s
Read how a 20-year wait for technology shows key insights in brain proteins’ role in the development and progression of Alzheimer’s.
Smithsonian honors St. Jude visionaries for ‘bubble boy’ cure
Read how St. Jude researchers and clinicians used gene therapy to cure the diabolical bubble boy disease.
Research homes in on drug to dampen inflammation fueling life-threatening immune disorder
Researchers have promising information that ruxolitinib may help treat a devastating auto-immune disorder.
Histiocytic disorders are the focus of annual meeting at St. Jude
Read how clinical experts and researchers are trying to shed some light on histiocytic disorders, which are both extremely rare and difficult to diagnose.